NCT03817684: A trial that was reported late by Tetra Discovery Partners
This trial has reported, although it was 853 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03817684 |
|---|---|
| Title | A Randomized , Double Blind, Placebo Controlled, 3-Arm Parallel Design Study to Evaluate the Effects of BPN14770 in Patients With Early Stage Alzheimer's Disease |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 30, 2019 |
| Completion date | Feb. 4, 2020 |
| Required reporting date | Feb. 3, 2021, midnight |
| Actual reporting date | June 7, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 853 |